Conjugate of bio-related substance and block polymer, and block polymer derivative for obtaining said conjugate

US12448488B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12448488-B2
Application numberUS-201917603275-A
CountryUS
Kind codeB2
Filing dateApr 15, 2019
Priority dateApr 15, 2019
Publication dateOct 21, 2025
Grant dateOct 21, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a modified bio-related substance that shows further prolonged half-life in blood and further improved stability in the blood of living organisms. In particular, the invention provides a conjugate of a block polymer and a bio-related substance, which conjugate is represented by the following formula (I), wherein each symbol is as described herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A conjugate of a block polymer and a bio-related substance, which is represented by the following formula (1): wherein A is a bio-related substance selected from the group consisting of a cytokine, a hormone, an enzyme, an antibody, and a nucleic acid, L 1 , L 2 , L 3 are each independently a single bond or a divalent linker, Q is a residue of a compound having 2 or 3 active hydrogens, m is 10-1400, n is 2-100, x is 1 or 2, R is a hydrogen atom or an acyl group, p is 1 or 2, and y is 1-40. 2. The conjugate according to claim 1 , wherein, in the formula (1), y is 1. 3. The conjugate according to claim 2 , wherein, in the formula (1), m is 40-1200 and n is 5-50. 4. The conjugate according to claim 3 , wherein, in the formula (1), Q is a residue of a compound selected from the group consisting of ethylene glycol, glycerol, lysine, aspartic acid and glutamic acid. 5. The conjugate according to claim 4 , wherein, in the formula (1), L 1 , L 2 , L 3 are each independently selected from the group consisting of a single bond, a phenylene group, an amide bond, an ether bond, a thioether bond, a urethane bond, a secondary amino group, a carbonyl group, a urea bond, a triazine group, a maleimide group added with thiol, an oxyme bond, and an alkylene group optionally containing one or more kinds selected from the group consisting of a single bond, a phenylene group, an amide bond, an ether bond, a thioether bond, a urethane bond, a secondary amino group, a carbonyl group, a urea bond, a triazine group, a maleimide group added with thiol and an oxyme bond. 6. The conjugate according to claim 2 , wherein, in the formula (1), Q is a residue of a compound selected from the group consisting of ethylene glycol, glycerol, lysine, aspartic acid and glutamic acid. 7. The conjugate according to claim 2 , wherein, in the formula (1), L 1 , L 2 , L 3 are each independently selected from the group consisting of a single bond, a phenylene group, an amide bond, an ether bond, a thioether bond, a urethane bond, a secondary amino group, a carbonyl group, a urea bond, a triazine group, a maleimide group added with thiol, an oxyme bond, and an alkylene group optionally containing one or more kinds selected from the group consisting of a single bond, a phenylene group, an amide bond, an ether bond, a thioether bond, a urethane bond, a secondary amino group, a carbonyl group, a urea bond, a triazine group, a maleimide group added with thiol and an oxyme bond. 8. The conjugate according to claim 1 , wherein, in the formula (1), m is 40-1200 and n is 5-50. 9. The conjugate according to claim 1 , wherein, in the formula (1), Q is a residue of a compound selected from the group consisting of ethylene glycol, glycerol, lysine, aspartic acid and glutamic acid. 10. The conjugate according to claim 1 , wherein, in the formula (1), L 1 , L 2 , L 3 are each independently selected from the group consisting of a single bond, a phenylene group, an amide bond, an ether bond, a thioether bond, a urethane bond, a secondary amino group, a carbonyl group, a urea bond, a triazine group, a maleimide group added with thiol, an oxyme bond, and an alkylene group optionally containing one or more kinds selected from the group consisting of a single bond, a phenylene group, an amide bond, an ether bond, a thioether bond, a urethane bond, a secondary amino group, a carbonyl group, a urea bond, a triazine group, a maleimide group added with thiol and an oxyme bond.

Assignees

Inventors

Classifications

  • Growth hormone [GH], i.e. somatotropin · CPC title

  • Polyamides, e.g. nylon (polyamino acids A61K47/62) · CPC title

  • the modifying agent being an organic compound · CPC title

  • Polyamides containing oxygen in the form of ether groups (C08G69/12, C08G69/32 take precedence) · CPC title

  • Alpha-amino-carboxylic acids {(polysuccinimides C08G73/1092)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12448488B2 cover?
The invention provides a modified bio-related substance that shows further prolonged half-life in blood and further improved stability in the blood of living organisms. In particular, the invention provides a conjugate of a block polymer and a bio-related substance, which conjugate is represented by the following formula (I), wherein each symbol is as described herein.
Who is the assignee on this patent?
Nof Corp, Univ Degli Studi Padova
What technology area does this patent fall under?
Primary CPC classification C08G81/028. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).